Market Place
Sourcing Support
XyloCor Therapeutics Dose First Patient in Phase 2b EXACT-2 Trial
10 Jul 2025 //
BUSINESSWIRE
XyloCor`s XC001 Positive EXACT Phase 2 Data Presented, Published
02 May 2024 //
BUSINESSWIRE
XyloCor hires Reinhardt as CMO to lead gene therapy programs
07 Aug 2019 //
FIERCE BIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.